These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 12955707

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Abnormal lipoprotein and apolipoprotein pattern in lipoprotein glomerulopathy.
    Oikawa S, Suzuki N, Sakuma E, Saito T, Namai K, Kotake H, Fujii Y, Toyota T.
    Am J Kidney Dis; 1991 Nov; 18(5):553-8. PubMed ID: 1951334
    [Abstract] [Full Text] [Related]

  • 4. Lipoprotein glomerulopathy-like disease in a patient with type III hyperlipoproteinemia due to apolipoprotein E2 (Arg158 Cys)/3 heterozygosity.
    Karube M, Nakabayashi K, Fujioka Y, Yoshihara K, Yamada A, Matsunaga A, Saito T.
    Clin Exp Nephrol; 2007 Jun; 11(2):174-179. PubMed ID: 17593519
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Lipoprotein glomerulopathy associated with the Osaka/Kurashiki APOE variant: two cases identified in Latin America.
    da Silveira-Neto JN, de Oliveira Ahn GJ, de Menezes Neves PDM, Baptista VAF, de Almeida Araújo S, Wanderley DC, Watanabe A, Watanabe EH, Murai NM, Bertollo EMG, Vieira-Neto OM, Dantas M, de Antônio SR, Costa RS, Baptista MASF, Moysés-Neto M, Onuchic LF.
    Diagn Pathol; 2021 Jul 26; 16(1):65. PubMed ID: 34311745
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Plasma level and genetic variation of apolipoprotein E in patients with lipoprotein glomerulopathy.
    Zhang B, Liu ZH, Zeng CH, Zheng JM, Chen HP, Zhou H, Li LS.
    Chin Med J (Engl); 2005 Apr 05; 118(7):555-60. PubMed ID: 15820086
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Lipoprotein glomerulopathy: significance of lipoprotein and ultrastructural features.
    Saito T, Oikawa S, Sato H, Sato T, Ito S, Sasaki J.
    Kidney Int Suppl; 1999 Jul 05; 71():S37-41. PubMed ID: 10412734
    [Abstract] [Full Text] [Related]

  • 16. A novel apolipoprotein E mutation, ApoE Osaka (Arg158 Pro), in a dyslipidemic patient with lipoprotein glomerulopathy.
    Mitani A, Ishigami M, Watase K, Minakata T, Yamamura T.
    J Atheroscler Thromb; 2011 Jul 05; 18(6):531-5. PubMed ID: 21325775
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The Novel Apolipoprotein E Mutation ApoE Chengdu (c.518T＞C, p.L173P) in a Chinese Patient with Lipoprotein Glomerulopathy.
    Wu H, Yang Y, Hu Z.
    J Atheroscler Thromb; 2018 Aug 01; 25(8):733-740. PubMed ID: 29398675
    [Abstract] [Full Text] [Related]

  • 19. Apolipoprotein E Sendai (arginine 145-->proline): a new variant associated with lipoprotein glomerulopathy.
    Oikawa S, Matsunaga A, Saito T, Sato H, Seki T, Hoshi K, Hayasaka K, Kotake H, Midorikawa H, Sekikawa A, Hara S, Abe K, Toyota T, Jingami H, Nakamura H, Sasaki J.
    J Am Soc Nephrol; 1997 May 01; 8(5):820-3. PubMed ID: 9176854
    [Abstract] [Full Text] [Related]

  • 20. A patient with apolipoprotein E2 variant (Q187E) without lipoprotein glomerulopathy.
    Hayakawa M, Okubo M, Katori H, Nagahama K, Murase T, Kobayashi T, Tanaka S, Nakanishi K, Odawara M, Matsushita H, Yamada A.
    Am J Kidney Dis; 2002 Mar 01; 39(3):E15. PubMed ID: 11877595
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.